<SEC-DOCUMENT>0001193125-23-009653-index.html : 20230118
<SEC-HEADER>0001193125-23-009653.hdr.sgml : 20230118
<ACCEPTANCE-DATETIME>20230117191532
ACCESSION NUMBER:		0001193125-23-009653
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20230118
DATE AS OF CHANGE:		20230117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Disc Medicine, Inc.
		CENTRAL INDEX KEY:			0001816736
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				851613057
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269270
		FILM NUMBER:		23532573

	BUSINESS ADDRESS:	
		STREET 1:		300 ONE KENDALL SQUARE, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		(617) 401-4400

	MAIL ADDRESS:	
		STREET 1:		300 ONE KENDALL SQUARE, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemini Therapeutics, Inc. /DE
		DATE OF NAME CHANGE:	20210209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FS Development Corp.
		DATE OF NAME CHANGE:	20200702
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>d283699ds3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: d283699ds3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d283699dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d283699dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d283699dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d283699dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>d283699dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 4 - file: d283699dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>d283699dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 5 - file: d283699dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g283699g00a03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g283699g00a03.jpg

</DOCUMENT>
</SEC-DOCUMENT>